Skip to content

Cetera Investment Advisers: FSEC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Cetera Investment Advisers on FSEC, newest first. How the timeline and the estimate are built.

Cetera Investment Advisers held 469,854 FSEC shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 469,854 shares
    Change vs previous 13F +84,688 shares

    0.02% of the 13F portfolio, value $20,598,414.

    13F-HR 0001666741-26-000004 filed by Cetera Investment Advisers
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 385,166 shares
    Change vs previous 13F +43,405 shares

    0.02% of the 13F portfolio, value $16,885,658.

    13F-HR 0001666741-26-000002 filed by Cetera Investment Advisers
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 341,761 shares
    Change vs previous 13F +325,877 shares

    0.02% of the 13F portfolio, value $15,081,933.

    13F-HR 0001666741-26-000001 filed by Cetera Investment Advisers
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 15,884 shares
    Change vs previous 13F +5,077 shares

    <0.01% of the 13F portfolio, value $700,504.

    13F-HR 0001085146-25-005999 filed by Cetera Investment Advisers
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 10,807 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $470,753.

    13F-HR 0001085146-25-004744 filed by Cetera Investment Advisers
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).